Implications of Myriad on IP Protection for Personalized Medicine and Protecting IP in US and China

9th Annual SABPA Pacific Forum

10/05/2013

Life Sciences

The Institute of the Americas, UCSD
10111 N Torrey Pines Road
La Jolla, CA 92037

Speaking Engagement

Peng Chen will be speaking at the 9th SABPA Pacific Forum that will be held on Saturday Oct. 5, 2013 at the Institute of the Americas, UCSD. As one of the flagship annual conferences organized by SABPA, Pacific Forum (PF) draws about 300 life sciences professionals from across the Pacific every year. The main themes of this year’s conference will include 1) cross-border collaborations in the pharmaceutical and biotech field that have effectively integrated resources to fuel innovative R&D and business in the Pacific Rim, and 2) recent trends in applying genomic technologies to improving human healthcare. Senior leaders from the R&D divisions of pharmaceutical and biotech companies, international IP experts, world-renowned researchers from universities and academic institutions, and executives of organizations from the Asia Pacific region will share their insights on a variety of exciting topics at this event.

Mr. Chen’s topic will be on, “Implications of Myriad on IP Protection for Personalized Medicine and Protecting IP in US and China.”

For more information, click here.

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2018 Morrison & Foerster LLP. All rights reserved.